Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Better Options for Chronic Cancer Pain: a SMART Study
NCT06574009Phase 4Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2025
- Primary completion
- Apr 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine in chronic pain, opioid use disorder (OUD), sponsored by VA Office of Research & Development. Started Oct 2025; status: recruiting.
02
Drugs
buprenorphine
03
Conditions
chronic painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06574009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06574009.